Modeling plasma virus concentration during primary HIV infection

Journal of Theoretical Biology

Volumn 203, Issue 3, 2000, Pages 285-301

  Stafford, Max A ^a,b   Corey, Lawrence ^c   Cao, Yunzhen ^d   Daar, Eric S ^e   Ho, David D ^d   Perelson, Alan S ^f  

^a TEXAS A AND M UNIVERSITY CORPUS CHRISTI   (United States)

^b SANTA FE INSTITUTE   (United States)

^c USA   (United States)

^d ROCKEFELLER UNIVERSITY   (United States)

^e CEDARS SINAI MEDICAL CENTER   (United States)

^f LOS ALAMOS NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LIFESPAN; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VIREMIA; VIRUS LOAD; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0034615789     PISSN: 00225193     EISSN: None     Source Type: Journal    
DOI: 10.1006/jtbi.2000.1076     Document Type: Article

References (57)

1. Virus dynamics and drug therapy
2. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus
3. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection
4. HIV-1 nef protein protects infected primary cells against killing by cytotoxic T lymphocytes
5. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1
6. Target cell limited and immune control models of HIV infection: A comparison
7. Modeling HIV infection of CD4+ T-cell subpopulations
8. Viral clearance without destruction of infected cells during acute HBV infection
9. Population biology of HIV-1 infection: Viral and CD4+ T cell demographics and dynamics in lymphatic tissues
10. Rapid turn-over of plasma virions and CD4 lymphocytes in HIV-1 infection
11. Model-based analysis of CD4+ lymphocyte dynamics in HIV infected individuals
12. Dramatic rise in plasma viremia after CD8+ T-cell depletion in SIV-infected macaques
13. Acute human immunodeficiency virus type 1 infection
14. Patterns of viral dynamics during primary human immunodeficiency virus type 1 infection
15. Role of the thymus in pediatric HIV-1 infection
16. Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection
17. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome
18. Viral dynamics of acute HIV-1 infection
19. IL-16 represses HIV-1 promoter activity
20. CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription
21. Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques
22. Population dynamics of HIV within an individual after treatment with zidovudine
23. A model of human immunodeficiency virus infection in T helper cell clones
24. Models of interactions between HIV and other pathogens
25. Modeling the interaction of HIV with cells of the immune response
26. Improved estimates for HIV-1 clearance rate and intracellular delay
27. A model of primary HIV-1 infection
28. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type I infection
29. The evolutionary dynamics of HIV-1 quasispecies and the development of immunodeficiency disease
30. Antigenic diversity thresholds and the development of AIDS
31. Population dynamics of immune responses to persistent viruses
32. Viral dynamics in primary viremia and anti-retroviral therapy in simian immunodeficiency virus infection
33. Anti-viral drug treatment: Dynamics of resistance in free virus and infected cell populations
34. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA
35. The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia
36. Modeling the interaction of the immune system with HIV
37. Dynamics of HIV infection of CD4 + T cells
38. Mathematical analysis of HIV-1 dynamics in vivo
39. HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time
40. Reduction of HIV concentration during acute infection: Independence from a specific immune response
41. Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis
42. Stability analysis of simple models for immune cells interacting with normal pathogens and immune system retroviruses
43. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors
44. Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS
45. Turnover of CD4 + and CD8 + T Lymphocytes in HIV-1 infection as measured by Ki-67 antigen
46. Clinical and epidemiologic features of primary HIV infection
47. A model for AIDS pathogenesis
48. Control of viremia in simian immunodeficiency virus infection by CD8 + lymphocytes
49. Preferential infection of CD4 + memory T cells by human immunodeficiency virus type-1: Evidence for a role in the selective T-cell functional defects observed in infected individuals
50. HIV-1 replication is controlled at the level of T cell activation and proviral integration
51. Analysis of a model for the pathogenesis of AIDS
52. CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication
53. Viral dynamics in human immunodeficiency virus type 1 infection
54. Characterization of viral dynamics in human immunodeficiency virus type-1 infected patients treated with combination antiretroviral therapy; Relationships to host factors, cellular restoration, and virologic end points
55. Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle
56. + T cells